UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Sells 484,352 Shares of Henry Schein, Inc. $HSIC

Key Points

• UBS AM reduced its stake in Henry Schein by 53.4%, selling 484,352 shares and holding 421,952 shares valued at approximately $28.9 million as of the latest SEC filing.
• Several institutional investors, including JPMorgan Chase and Burgundy Asset Management, have increased their stakes in Henry Schein, indicating ongoing interest in the company's stock despite recent sell-offs.
• Henry Schein's stock is currently rated as a "Hold" by analysts, with a consensus target price of $76.67 and a recent quarterly earnings report that missed expectations but showed revenue growth.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 53.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 421,952 shares of the company's stock after selling 484,352 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 0.35% of Henry Schein worth $28,899,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. JPMorgan Chase & Co. boosted its stake in Henry Schein by 6.5% during the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock worth $436,489,000 after acquiring an additional 390,399 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Henry Schein by 4.8% during the first quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company's stock worth $153,480,000 after purchasing an additional 103,384 shares during the period. Burgundy Asset Management Ltd. raised its position in shares of Henry Schein by 33.9% during the first quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company's stock worth $153,105,000 after purchasing an additional 566,530 shares during the period. Clarkston Capital Partners LLC raised its position in shares of Henry Schein by 0.4% during the first quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company's stock worth $119,965,000 after purchasing an additional 7,345 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Henry Schein by 1.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company's stock worth $82,440,000 after purchasing an additional 11,999 shares during the period. Institutional investors own 96.62% of the company's stock.

Analyst Ratings Changes

HSIC has been the topic of a number of research analyst reports. Leerink Partners set a $75.00 price target on Henry Schein in a research report on Monday, July 14th. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Evercore ISI raised Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target on the stock in a research report on Tuesday, August 26th. JPMorgan Chase & Co. dropped their price target on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Finally, UBS Group dropped their target price on Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 6th. Five equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, Henry Schein presently has an average rating of "Hold" and a consensus target price of $76.67.

Henry Schein Stock Down 0.3%

NASDAQ:HSIC opened at $68.81 on Tuesday. The firm has a market capitalization of $8.34 billion, a price-to-earnings ratio of 22.20, a price-to-earnings-growth ratio of 2.28 and a beta of 0.86. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The stock's 50 day moving average price is $69.23 and its two-hundred day moving average price is $69.42. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period last year, the firm earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.